PDCD1LG2 and neoplasm: In B cells, PRDM16 and DNMT3A for AML, PDCD1LG2 for Hodgkin’s lymphoma, LMNA for spritzed tumor, and BCL11B for T-cell acute lymphoblastic leukemia (T-ALL) harbored DMPs for HIV infection.